$SKB BIO-B(06990)$ 科伦博泰生物-B（06

88
1
Favorite

盲炳
2025-06-17

$SKB BIO-B(06990)$ 科伦博泰生物-B（06990）极具投资买入价值。从研发成果看，它拥有涵盖ADC、大分子、小分子靶向药的技术平台，打造了约20个分子的药物管线。其核心产品芦康沙妥珠单抗作为国产首个TROP2 ADC ，优势明显。而且，它与默沙东深度合作，交易对价超百亿美元，全球研发稳步推进。从市场表现来看，高盛等多家机构给予“买入”评级，2025年SKB264销售前景乐观，有望冲击10亿元销售收入，潜力巨大。

06990

06-17 14:35

HKSKB BIO-B

Side	Price \| Filled	Realized P&L
Buy Open	328.80 200	-- Closed

SKB BIO-B

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Top
Latest

Trade Feed Decoder
·2025-06-17
TOP
当前评论仅支持在app查看。
Reply
Like
Report

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":447017964253352,"tweetId":"447017964253352","gmtCreate":1750142178747,"gmtModify":1750251767065,"author":{"id":4160043317841132,"idStr":"4160043317841132","authorId":4160043317841132,"authorIdStr":"4160043317841132","name":"盲炳","avatar":"https://community-static.tradeup.com/news/b36a6c05b78a7183f709007b5caf47ac","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":13,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.15","individualDisplayEnabled":0},"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.20","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":633,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":463,"starInvestorOrderShareNum":1290,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":94.46,"showRor":true,"investmentPhilosophy":"日日難過日日過，天天難贏天天驘!","winRationPercentage":87.531172,"tradeVolumeEst":0},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/06990\">$SKB BIO-B(06990)$&nbsp;</a>科伦博泰生物-B（06990）极具投资买入价值。从研发成果看，它拥有涵盖ADC、大分子、小分子靶向药的技术平台，打造了约20个分子的药物管线。其核心产品芦康沙妥珠单抗作为国产首个TROP2 ADC ，优势明显。而且，它与默沙东深度合作，交易对价超百亿美元，全球研发稳步推进。从市场表现来看，高盛等多家机构给予“买入”评级 ，2025年SKB264销售前景乐观，有望冲击10亿元销售收入，潜力巨大。</body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/06990\">$SKB BIO-B(06990)$&nbsp;</a>科伦博泰生物-B（06990）极具投资买入价值。从研发成果看，它拥有涵盖ADC、大分子、小分子靶向药的技术平台，打造了约20个分子的药物管线。其核心产品芦康沙妥珠单抗作为国产首个TROP2 ADC ，优势明显。而且，它与默沙东深度合作，交易对价超百亿美元，全球研发稳步推进。从市场表现来看，高盛等多家机构给予“买入”评级 ，2025年SKB264销售前景乐观，有望冲击10亿元销售收入，潜力巨大。</body></html>","text":"$SKB BIO-B(06990)$ 科伦博泰生物-B（06990）极具投资买入价值。从研发成果看，它拥有涵盖ADC、大分子、小分子靶向药的技术平台，打造了约20个分子的药物管线。其核心产品芦康沙妥珠单抗作为国产首个TROP2 ADC ，优势明显。而且，它与默沙东深度合作，交易对价超百亿美元，全球研发稳步推进。从市场表现来看，高盛等多家机构给予“买入”评级 ，2025年SKB264销售前景乐观，有望冲击10亿元销售收入，潜力巨大。","highlighted":1,"essential":1,"paper":1,"likeSize":88,"commentSize":1,"repostSize":12,"favoriteSize":0,"link":"https://ttm.financial/post/447017964253352","repostId":0,"isVote":1,"tweetType":1,"viewCount":2351,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["06990"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4160043317841132","orderId":"39484512135564288","kind":"TRADE","symbol":"06990","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/06990\">$SKB BIO-B(06990)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/06990","symbolName":"SKB BIO-B","market":"HK","action":"BUY","currency":"HKD","symbolLogo":"","showFilledQuantity":true,"nameCN":"SKB BIO-B","orderType":"LMT","filledQuantityFinal":200,"avgFillPrice":328.8,"createTime":1750142123,"filledQuantity":"200","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"SKB BIO-B","contractExtraDescription":"06990","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":0.0251},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":337,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":447009010139544,"commentId":"447009010139544","gmtCreate":1750147839896,"gmtModify":1750148126537,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":447017964253352,"objectIdStr":"447017964253352","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"当前评论仅支持在app查看。","text":"当前评论仅支持在app查看。","html":"当前评论仅支持在app查看。","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}